Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q4 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.